Navigation Links
Cell Therapeutics Reports Second Quarter 2013 Financial Results
Date:7/31/2013

SEATTLE, July 31, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the second quarter and six months ended June 30, 2013.

"The second quarter was highlighted by the substantial progress we made in our reimbursement discussions for PIXUVRI® (pixantrone) in Europe, specifically in the UK and Italy," said James Bianco, M.D., President and CEO of CTI. "In particular, we look forward to our planned launch of PIXUVRI in Italy, where AIFA granted market access to bring this new approved therapy to patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have failed 2 or 3 prior regimens.  In addition, PERSIST-1, our randomized Phase 3 clinical trial designed to evaluate the safety and efficacy of pacritinib compared to best available therapy, excluding JAK inhibitors, continues to enroll patients with myelofibrosis.  A second planned Phase 3 trial is on track to initiate later this year."

Second Quarter 2013 and Recent HighlightsPIXUVRI® (pixantrone) Commercial:  Reimbursement Progress in Top European Markets

  • Received notice in July that market access in Italy was granted by the Italian Medicines Agency (AIFA) for PIXUVRI as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell NHL (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy). 
  • Received notice in July that the UK's Department of Health approved CTI's patient access scheme relating to PIXUVRI.  An independent appraisal committee of the National Institute for Health and Clinical Excellence (NICE) is scheduled to consider the new evidence on the cost effectiveness of PIXVURI at its meeting in September 2013.
  • Announced in May that Germany's Federal Joint Committee (G-BA) reported that additional benefit could not be determined for PIXUVRI versus the c
    '/>"/>

  • SOURCE Cell Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
    2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
    3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
    7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
    8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
    9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
    10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
    11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/7/2015)... BioRx, a Diplomat company (NYSE: DPLO ) announced that ... based on a survey held region-wide. The survey ... Philadelphia -based research firm called Workplace Dynamics. The ... across the Greater Cincinnati and ... workplace environment to overall organizational health. Once the surveys were ...
    (Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... Welch Allyn for $2 billion in cash and ... competitive patient monitoring market, according to Kalorama Information. ... heretofore participated in the medical device and advanced ... maker of hospital beds, patient lifting devices, and ...
    (Date:7/7/2015)... 2015   ICD-10 Charts ( www.icd10charts.com ) ... it has officially launched its newest line of ... and the new 4 Step ICD-10 Implementation Plan.  ... other ICD-10 Charts resources and mobile apps, are ... free-of-charge.  With the release of these resources, the ...
    Breaking Medicine Technology:BioRx Named a Top Workplace in 2015 by Enquirer Media 2BioRx Named a Top Workplace in 2015 by Enquirer Media 3Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4
    ... 2007 /PRNewswire/ -- A new Harris Poll,suggests that the ... effective than the vaccines used in some previous years. ... only 24 percent,less likely to get the flu than ... two previous Harris Polls on the same,topic.(1) In the ...
    ... study showed significant,results in favor of alemtuzumab versus ... 2007,/PRNewswire-FirstCall/ -- Genzyme Corporation and Bayer HealthCare,Pharmaceutical today ... study. This interim analysis of all patient data,through ... the study for,all patients showed that a once-yearly ...
    Cached Medicine Technology:Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 2Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 3Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 4Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 5Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 2Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 3Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 4Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 5Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 7Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 8Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 9
    (Date:7/7/2015)... Los Angeles, CA (PRWEB) , ... July 07, ... ... the International Business Times highlights rumors about possible facial rejuvenation that have emerged ... 67 year-old former U.S. Secretary of State looks more youthful than she has ...
    (Date:7/7/2015)... , ... July 07, 2015 , ... Greatist ... and website that helps active people find the most fun activities to do with ... coverage for millennials. It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. ...
    (Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation centers ... to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its ... are committed to making sure patients have access to cannabis as a viable ...
    (Date:7/7/2015)... ... 07, 2015 , ... At the end of June Pacific Prime Renewals team in Hong Kong ... initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce but eventually ... initiative Cotton explained, “We send anything between 300 and 600 pieces of paper per month. ...
    (Date:7/7/2015)... , ... July 07, 2015 , ... ... further enhance the experience for its patient community using its IDF ePHR, an ... patients with primary immunodeficiency diseases (PI) to easily track their health information, including ...
    Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
    ... the common diarrhea-causing disease , WEDNESDAY, Jan. 27 (HealthDay ... lives of millions of children in developing nations who ... studies show. , A study conducted in Malawi and ... life-threatening rotavirus in infants by more than 61 percent. ...
    ... ... cancer charity partners with the Vehicle Donation Processing Center to provide financial assistance to ... ... has partnered with the Vehicle Donation Processing Center, Inc. to launch a vehicle and ...
    ... NEWTOWN, Pa. , Jan. 27 CONNEXION ... Rob Naticchia as Executive Vice President, Client Services. In ... and development of CXHC, including its Clinical CONNEXION and Publication ... 15 years of pharmaceutical marketing and sales experience.  Most recently, ...
    ... , , ... the poorest nation in the Western Hemisphere.  It has practically nothing.  Although ... stationed where the quake hit the hardest. , Orphans International Worldwide Haiti ... Province, survived the earthquake unscathed.  An upcoming benefit in New York ...
    ... Adults with chronic rhinosinusitis a debilitating inflammation of the ... back report significantly improved quality of life following ... study led by Oregon Health & Science University (OHSU). ... Otolaryngology Head and Neck Surgery . ...
    ... ... a devastating magnitude-7.0 earthquake rocked Haiti, the global humanitarian organization Save the Children has ... , ... January 27, 2010 -- Two weeks after a devastating magnitude-7.0 earthquake rocked Haiti, the ...
    Cached Medicine News:Health News:Rotavirus Vaccine Could Save Millions of Children Worldwide 2Health News:Rotavirus Vaccine Could Save Millions of Children Worldwide 3Health News:Rotavirus Vaccine Could Save Millions of Children Worldwide 4Health News: The Breast Cancer Society Launches Vehicle Donation Program 2Health News: The Breast Cancer Society Launches Vehicle Donation Program 3Health News:Robert Naticchia Joins CONNEXION Healthcare as Executive Vice President, Client Services 2Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 2Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 3Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 4Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 5Health News:Surgery helps chronic sinusitis sufferers get relief 2Health News:Two Weeks After Haiti Quake, Save the Children Helps More Than 105,000 Children and Families with Food, Medicines, Basic Supplies 2Health News:Two Weeks After Haiti Quake, Save the Children Helps More Than 105,000 Children and Families with Food, Medicines, Basic Supplies 3
    Slick® Disposable Endotracheal Stylet, Nylon-coated wire, Malleable core, Sureloc Stop helps maintain desired length for patient safety. Handle forming capability for better grip. Sterile. Single...
    ... Requires minimal cervical spine manipulation. Prevent ... or nasally. Cost effective alternative to X-ray. ... of the soft tissues in the neck. ... location of the trachea relative to the ...
    ... Aaron manufactures two groups of flexible lighting ... and non-sterile in three different sizes 5", ... shaft portion of the light). These lights ... light is needed., ,The second group ...
    ... manufactures two groups of flexible lighting products. ... non-sterile in three different sizes 5", 10", ... portion of the light). These lights are ... is needed., ,The second group of ...
    Medicine Products: